Immune system via innate immune potentiation

The term "immune system via innate immune potentiation" refers to approaches that enhance the activity of the **innate immune system**, which provides immediate, non-specific defense against pathogens using pattern recognition receptors, phagocytes, and inflammatory mediators[1][3][5][6]. Potentiation can involve activation of pattern recognition receptors (e.g., Toll-like receptors), induction of trained immunity (epigenetic/metabolic alterations in innate immune cells), or direct stimulation of cytokine production[2][3]. Such strategies are relevant for infectious diseases, cancer immunotherapy, and vaccine adjuvants, but lack specificity for a single target and therefore do not have standard biomarkers or interacting drugs ascribed to a unique molecular entity. Because the entry is mechanistic and not a defined biomolecule or receptor, it is not considered a “therapeutic target” in a conventional sense and the name is overly broad[1][2][3][4][5][6].

Other names

Innate immune potentiationEnhancement of innate immunityPotentiation of innate immune response

Activation of pattern recognition receptors (e.g., Toll-like receptors); Stimulation of innate immune cells (macrophages, dendritic cells, NK cells); Induction of cytokines and chemokines; Epigenetic reprogramming of innate immune cells (trained immunity)